all report title image

ANTIDEPRESSANT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Antidepressant Market, By Drug Class (Selective Serotonin Reuptake Inhibitors (SSRIs) (Fluoxetine, Sertraline, and Others), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) (Venlafaxine, Duloxetine, and Others), Tricyclic Antidepressants (TCAs), Monoamine Oxidase Inhibitors (MAOIs), and Atypical Antidepressants), By Route of Administration (Oral, Subcutaneous, Intravenous, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

  • Published In : Aug 2024
  • Code : CMI7243
  • Pages :167
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Antidepressant Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
  • Eli Lilly and Company
  • Pfizer Inc.
  • GlaxoSmithKline PLC
  • AstraZeneca
  • AbbVie Inc.
  • Johnson & Johnson
  • H. Lundbeck AS
  • Sanofi
  • Bristol-Myers Squibb
  • Alkermes Plc
  • F. Hoffmann-La Roche Ltd
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Neurocrine Biosciences, Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Indivior PLC
  • Aurobindo Pharma

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.